Magnus Walter

Magnus joined Monte Rosa Therapeutics from AbbVie Germany, where he led Discovery Research focused on Alzheimer’s and Parkinson’s disease as Senior Director and Senior Research Fellow in Neuroscience from 2018. Prior to this, he spent 17 years at Eli Lilly, holding a number of leadership positions including Chief Scientific Officer for Global Neuroscience Medicinal Chemistry and Head of Chemistry UK. Magnus began his career at AstraZeneca after completing his DPhil from the University of Oxford and a Master’s degree in Chemistry from the University of Bonn.